Immunoluminometric assay of chromogranin A in serum with commercially available reagents.

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Clinical Chemistry

• Publication date

  1992-11-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1093/CLINCHEM/38.11.2267PMID 1424122
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Chromogranin A in familial pheochromocytoma: diagnostic screening value, prediction of tumor mass, and post-resection kinetics indicating two-compartment distribution.

  1990cited by this paper
• Chromogranin A in uremia: progressive retention of immunoreactive fragments.

  1990cited by this paper
• Enzyme-linked immunosorbent assay for chromogranin A.

  1989cited by this paper
• Rapid radioimmunoassay of circulating chromogranin A: in vitro stability, exploration of the neuroendocrine character of neoplasia, and assessment of the effects of organ failure.

  1989cited by this paper
• Hormone-negative, chromogranin A-positive endocrine tumors.

  1989cited by this paper
• Secretion of chromogranin A by peptide-producing endocrine neoplasms.

  1986cited by this paper
• Human chromogranin A. Purification and characterization from catecholamine storage vesicles of human pheochromocytoma.

  1984cited by this paper
• Radioimmunoassay of chromogranin A in plasma as a measure of exocytotic sympathoadrenal activity in normal subjects and patients with pheochromocytoma.

  1984cited by this paper

• Increased chromogranin a and carcinoid syndrome-like symptoms in a patient treated with duloxetine.

  2014cites this paper
• Plasma and Urinary Metanephrines Determined by an Enzyme Immunoassay, but not Serum Chromogranin A for the Diagnosis of Pheochromocytoma in Patients with Adrenal Mass

  2012cites this paper
• Verification of endocrinological functions at a short distance between parametric speakers and the human body.

  2011cites this paper
• Feasibility of testing three salivary stress biomarkers in relation to naturalistic traffic noise exposure.

  2010cites this paper
• Chromogranin A assay in clinical practice.

  2010cites this paper
• Chromogranin A assay in clinical practice Dosage de chromogranine A en pratique clinique

  2010cites this paper
• The effects of parametric speaker sound on salivary hormones and a subjective evaluation.

  2010cites this paper
• Tumeurs endocrines gastro-entéro-pancréatiques (TE GEP). Classifications, présentations cliniques, marqueurs biologiques

  2008cites this paper
• Efficacy and Tolerability of Pegylated IFN-α in Patients with Neuroendocrine Gastroenteropancreatic Carcinomas

  2006cites this paper
• Doxorubicin and streptozotocin after failed biotherapy of neuroendocrine tumors

  2005cites this paper
• Circulating levels of angiogenic cytokines can predict tumour progression and prognosis in neuroendocrine carcinomas

  2005cites this paper
• Adrenal incidentaloma diagnosed as pheochromocytoma by plasma chromogranin A and plasma metanephrines

  2005cites this paper
• The long-acting somatostatin analogue octreotide alleviates symptoms by reducing posttranslational conversion of prepro-glucagon to glucagon in a patient with malignant glucagonoma, but does not prevent tumor growth

  2004cites this paper
• Prospective, randomized, multicenter trial on the antiproliferative effect of lanreotide, interferon alfa, and their combination for therapy of metastatic neuroendocrine gastroenteropancreatic tumors--the International Lanreotide and Interferon Alfa Study Group.

  2003cites this paper
• [Chromogranin A: a marker of neuroendocrine tumors].

  2002cites this paper
• Méthodologie et utilisation du dosage de la chromogranine A en biologie clinique

  2001cites this paper
• Chromogranin A assay and (131)I-MIBG scintigraphy for diagnosis and follow-up of pheochromocytoma.

  2001cites this paper
• A new human chromogranin 'A' immunoradiometric assay for the diagnosis of neuroendocrine tumours

  2001cites this paper
• Characterisation of N-terminal chromogranin A and chromogranin B in mammals by region-specific radioimmunoassays and chromatographic separation methods.

  2000cites this paper
• Measurements of chromogranins and chromogranin-related peptides by immunological methods.

  2000cites this paper
• MEASUREMENTS OF CHROMOGRANINS AND IMMUNOLOGICAL METHODS CHROMOGRANIN-RELATED PEPTIDES BY

  2000cites this paper
• A new human chromogranin A (CgA) immunoradiometric assay involving monoclonal antibodies raised against the unprocessed central domain (145-245)

  1999cites this paper
• The ultimate biochemical diagnosis of neuroendocrine gastro-enteropancreatic tumours.

  1996cites this paper
• Efficient symptomatic control of carcinoid tumors with somatostatin in patients with disease progression under alpha-interferon therapy.

  1995cites this paper
• The use of chromogranin, synaptophysin and islet amyloid polypeptide as markers for neuroendocrine tumours.

  1995cites this paper
• Measurements of chromogranin A, chromogranin B (secretogranin I), chromogranin C (secretogranin II) and pancreastatin in plasma and urine from patients with carcinoid tumours and endocrine pancreatic tumours.

  1995cites this paper
• Immunoassays for measurement of chromogranin A and pancreastatin-like immunoreactivity in humans: correspondence in patients with neuroendocrine neoplasia.

  1994cites this paper
• Gastroenteropancreatic tumor imaging with somatostatin receptor scintigraphy.

  1994cites this paper
• Establishment and characterization of two Merkel cell tumor cultures.

  1994cites this paper
• Somatostatin-receptor imaging of neuroendocrine gastroenteropancreatic tumors.

  1993cites this paper